GlassScriptPhysician profile
Brian Jacob Herschorn
NPI 1578552550
$2,236.99
in general payments reported to CMS, 2019-2025
22 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $152 · 2021: $304 · 2022: $339 · 2023: $399 · 2024: $547 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.80 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $389.17 | 2019-2023 | |
| Amgen INC. | $372.51 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $260.95 | 2020-2023 | Tepezza |
| Glaukos Corporation | $166.78 | 2024 | Idose |
| Tarsus Pharmaceuticals, INC. | $139.49 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $138.89 | 2022-2024 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $105.47 | 2020-2022 | |
| Rxsight INC | $97.91 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Sun Pharmaceutical Industries INC. | $96.19 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $89.88 | 2021-2022 | |
| Alcon Vision LLC | $58.14 | 2022-2024 | Rocklatan |
| Shire North American Group INC | $49.82 | 2019 | |
| Kala Pharmaceuticals, INC. | $39.92 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $34.08 | 2024 | Syfovre |
| Abbvie INC. | $31.17 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $30.99 | 2022 | |
| Mallinckrodt Hospital Products INC. | $29.59 | 2025 | Acthar |
| Dompe US, INC. | $28.13 | 2022 | |
| Harrow Eye, LLC | $23.64 | 2024 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.38 | 2020 | |
| Bausch & Lomb Americas INC. | $17.84 | 2023 | Miebo |
| Akorn Operating Company LLC | $15.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Herschorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.